NIPT
Non-invasive prenatal testing
Modern non-invasive prenatal testing that allows for the detection of chromosomal abnormalities in the fetus through DNA analysis from the mother's venous blood.
All NIPT tests: Free consultative support from a geneticist in the presence of a high-risk conclusion
NIPT T21
Detects risk of 1 condition
- ✔Down syndrome
- ✘Edwards syndrome
- ✘Patau syndrome
- ✘Rare autosomal aneuploidies
- ✘Turner syndrome
- ✘Klinefelter syndrome
- ✘Trisomy X
- ✘Jacob’s syndrome
- ✘Microdeletion syndromes
- ✘Microduplication syndromes
- ✔Fetal sex determination (optional)
- ✔For twin pregnancies
NIPT Basic (3T)
Detects risk of 3 conditions
- ✔Down syndrome
- ✔Edwards syndrome
- ✔Patau syndrome
- ✘Rare autosomal aneuploidies
- ✘Turner syndrome
- ✘Klinefelter syndrome
- ✘Trisomy X
- ✘Jacob’s syndrome
- ✘Microdeletion syndromes
- ✘Microduplication syndromes
- ✔Fetal sex determination (optional)
- ✔For twin pregnancies
NIPT Standard (7T)
Detects risk of 9 conditions
- ✔Down syndrome
- ✔Edwards syndrome
- ✔Patau syndrome
- ✘Rare autosomal aneuploidies
- ✔Turner syndrome
- ✔Klinefelter syndrome
- ✔Trisomy X
- ✔Jacob’s syndrome
- ✘Microdeletion syndromes
- ✘Microduplication syndromes
- ✔Fetal sex determination (optional)
- ✘For twin pregnancies
NIPT Expanded (MAX)
Detects risk of 72 conditions
- ✔Down syndrome
- ✔Edwards syndrome
- ✔Patau syndrome
- ✔Rare autosomal aneuploidies
- ✔Turner syndrome
- ✔Klinefelter syndrome
- ✔Trisomy X
- ✔Jacob’s syndrome
- ✔Microdeletion syndromes
- ✔Microduplication syndromes
- ✔Fetal sex determination (optional)
- ✘For twin pregnancies
Non-invasive prenatal testing (NIPT)
Non-invasive prenatal testing (NIPT) is a modern genetic method that allows for the assessment of the risk of chromosomal abnormalities in the fetus through the analysis of blood from the pregnant woman.
Starting from the 10th week of pregnancy, fragmented fetal DNA circulates in the mother's blood, which can be studied without risk to the health of the woman and the future child.
Unlike biochemical screening, NIPT specifically assesses the genetic material of the fetus, ensuring high accuracy.
NIPT is a safe, non-invasive method with high sensitivity (≈99% for trisomies 21, 18, and 13).
NIPT can be performed as early as the 10th week of pregnancy. Preparation is minimal: a standard blood draw from a vein.
Chromosomal aneuploidy risk calculator by maternal age
How to take the test
You can take the test at our collection point at:
Tashkent, 1st Rakatboshi passage, 17
Blood collection takes no more than 10 minutes. Results are available online or in print.
Non-invasive prenatal testing in the Genscreen Laboratory
International experience
Experts with years of practice in genetics, laboratory diagnostics and bioinformatics.
Confidentiality guarantee
We strictly follow the privacy policy: information is not shared with third parties without consent.
Personal consultation
Online consultation is available to explain results after the study.
Reliability and control
Every research stage is under strict supervision and multiple checks.
Technological leadership
Modern equipment and international diagnostic standards.
Transparent pricing
Clear costs without hidden fees, with the option to choose the most suitable test.